UY27035A1 - Derivados de imidazolona para el tratamiento de enfermedades virales - Google Patents

Derivados de imidazolona para el tratamiento de enfermedades virales

Info

Publication number
UY27035A1
UY27035A1 UY27035A UY27035A UY27035A1 UY 27035 A1 UY27035 A1 UY 27035A1 UY 27035 A UY27035 A UY 27035A UY 27035 A UY27035 A UY 27035A UY 27035 A1 UY27035 A1 UY 27035A1
Authority
UY
Uruguay
Prior art keywords
compounds
treatment
imidazolone derivatives
viral diseases
formula
Prior art date
Application number
UY27035A
Other languages
English (en)
Inventor
B W Dymock
D S Walter
J H Merret
K E Burdon Parkes
M J Parrat
P S Jones
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of UY27035A1 publication Critical patent/UY27035A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invención describe nuevos derivados de imidazolona así como los éteres o ésteres hidrolizables de compuestos de fórmula I y sales farmacéuticamente aceptables de los mismos, un proceso para su elaboración, composiciones farmacéuticas y el uso de tales compuestos en medicina en donde R1, R2, R3, A y X son tal como se definen en la descripción. Los compuestos de fórmula I son inhibidores de la enzima transcriptasa reversa del virus de la inmunodeficiencia humana que está implicado en la replicación viral. Por consiguiente los compuestos de esta invención se pueden usar ventajosamente como agentes terapéuticos para procesos mediados por VIH.
UY27035A 2000-11-22 2001-11-21 Derivados de imidazolona para el tratamiento de enfermedades virales UY27035A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0028484.4A GB0028484D0 (en) 2000-11-22 2000-11-22 Imidazolone derivatives for the treatment of viral diseases

Publications (1)

Publication Number Publication Date
UY27035A1 true UY27035A1 (es) 2002-06-20

Family

ID=9903671

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27035A UY27035A1 (es) 2000-11-22 2001-11-21 Derivados de imidazolona para el tratamiento de enfermedades virales

Country Status (20)

Country Link
US (1) US6518293B2 (es)
EP (1) EP1341766B1 (es)
JP (1) JP2004514672A (es)
KR (1) KR100528760B1 (es)
CN (1) CN1633417A (es)
AR (1) AR035372A1 (es)
AT (1) ATE307805T1 (es)
AU (2) AU2002221842B2 (es)
BR (1) BR0115476A (es)
CA (1) CA2428461A1 (es)
DE (1) DE60114448T2 (es)
DK (1) DK1341766T3 (es)
ES (1) ES2251529T3 (es)
GB (1) GB0028484D0 (es)
MX (1) MXPA03004454A (es)
PA (1) PA8533301A1 (es)
PE (1) PE20020636A1 (es)
UY (1) UY27035A1 (es)
WO (1) WO2002042279A1 (es)
ZA (1) ZA200303690B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
WO2005100322A1 (en) * 2004-04-14 2005-10-27 Pfizer Limited Sulphur-linked imidazole compounds for the treament of hiv
CA2592909A1 (en) * 2005-01-06 2006-07-13 Pfizer Limited Imidazole derivatives as enzyme reverse transcriptase modulators
WO2008085008A1 (en) * 2007-01-11 2008-07-17 Mogam Biotechnology Research Institute T-cell inhibiting compounds and their use for the treatment of t-cell-mediated diseases
KR101110120B1 (ko) * 2009-10-28 2012-01-31 주식회사 케이아이테크놀로지 표지판 완충장치

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4345936A (en) * 1981-10-05 1982-08-24 Eli Lilly And Company Imidazoles, compositions and herbicidal method
TW235963B (es) 1992-01-16 1994-12-11 Shionogi & Co
EP0627423A4 (en) 1992-01-22 1995-02-15 Nissan Chemical Ind Ltd SUBSTITUTED PYRAZOLE DERIVATIVES AND BACTERICIDES FOR AGRICULTURE AND GARDENING.
GB9222262D0 (en) 1992-10-23 1992-12-09 Merck Sharp & Dohme Therapeutic agents
US5612636A (en) * 1995-01-19 1997-03-18 Texas Instruments Incorporated Short circuit power optimization for CMOS circuits
US5612363A (en) 1995-06-02 1997-03-18 Berlex Laboratories, Inc. N,N-di(aryl) cyclic urea derivatives as anti-coagulants
US6046331A (en) * 1998-12-17 2000-04-04 Synaptic Pharmaceutical Corporation Imidazolones and their use in treating benign prostatic hyperplasia and other disorders

Also Published As

Publication number Publication date
KR100528760B1 (ko) 2005-11-15
AU2002221842B2 (en) 2007-08-23
DK1341766T3 (da) 2006-02-20
KR20030060951A (ko) 2003-07-16
JP2004514672A (ja) 2004-05-20
CA2428461A1 (en) 2002-05-30
EP1341766A1 (en) 2003-09-10
MXPA03004454A (es) 2003-08-19
ATE307805T1 (de) 2005-11-15
DE60114448D1 (de) 2005-12-01
GB0028484D0 (en) 2001-01-10
WO2002042279A1 (en) 2002-05-30
ES2251529T3 (es) 2006-05-01
PE20020636A1 (es) 2002-07-18
BR0115476A (pt) 2003-08-19
US20020107272A1 (en) 2002-08-08
DE60114448T2 (de) 2006-07-06
AU2184202A (en) 2002-06-03
US6518293B2 (en) 2003-02-11
ZA200303690B (en) 2004-08-13
PA8533301A1 (es) 2002-08-26
AR035372A1 (es) 2004-05-12
CN1633417A (zh) 2005-06-29
EP1341766B1 (en) 2005-10-26

Similar Documents

Publication Publication Date Title
GT200100201A (es) Derivados de pirazol para el tratamiento der enfermedades viricas.
UY28059A1 (es) Nuevos derivados de dihidropirimido (4,5-d) pirimidona sustituida por amino. fabricacion y uso de los mismos como agentes farmaceuticos.
UY28578A1 (es) Derivados de amida
UY29301A1 (es) Derivados amida
UY29199A1 (es) Derivados tiazol, composiciones que los contienen, procedimientos de preparación y aplicaciones
AR024227A1 (es) Pirimidinas inhibidoras de replicacion de hiv, un proceso para su preparacion, el uso de las mismas para la manufactura de un medicamento, composiciones farmaceuticas, y un proceso para prepararlas
ECSP109935A (es) Derivados de morfolino pirimidina utilizados en enfermedades relacionadas con mtor quinasa y/o pi3k
UY32462A (es) Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644
DOP2002000378A (es) Derivados de pirazol para el tratamiento del vih
AR005053A1 (es) Compuestos de difenilhexano, un procedimiento para su preparacion, composiciones farmaceuticas y el uso de dichos compuestos, y procedmientos para la manufactura de medicamentos para inhibir la infeccion de hiv
ECSP088974A (es) Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3)
ECSP066313A (es) Derivados de la piridazina y su uso como agentes terapéuticos
ECSP066315A (es) Derivados de la piridazina y su uso como agentes terapéuticos
CL2004000590A1 (es) Compuestos derivados de 1,3,4-oxadiazol-3-ona, 1,3,4-tiadiazol-2-ona y de 1,2,4-triazol-3-ona; composicion farmaceutica que los contiene; procedimiento de preparacion y su uso en la preparacion de un medicamento en los que esta relacionado el virus v
ECSP066312A (es) Derivados piridilo y su uso como agentes terapéuticos
MX9204454A (es) Derivados de tiourea para inhibir la replicacion del virus de inmunodeficiencia humana y formulado farmaceutico que los contiene.
BR0309012A (pt) Uso de um composto, formulação farmacêutica, composto, composição farmacêutica, e, processo para a preparação de um composto
BRPI0512252A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto
HN2008001666A (es) Derivados acidos de cicloalquilamino
BRPI0409498A (pt) uso de um composto, formulação farmacêutica, composto, composição farmacêutica, e, processo para preparação de um composto
BR0210158A (pt) Derivados de pirazol como inibidores da transcriptase reversa do hiv
UY27786A1 (es) Derivados de isoquinolina.
GT200100111A (es) Derivados de pirrol
CL2021003034A1 (es) Métodos de tratamiento del síndrome de sjögren utilizando un inhibidor de la tirosina quinasa de bruton
UY29739A1 (es) Derivados de amidas o sales farmacéuticamente aceptables de los mismos, procesos de preparaciones farmacéuticas conteniéndolos y aplicaciones

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20141114